XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net income $ 76,880 $ 1,093
Adjustments to reconcile net income to cash flow from operating activities:    
Depreciation and amortization 78,174 16,552
Accretion of loan discounts and premiums, net (2,754) 0
Amortization of deferred financing costs, net 919 364
Stock compensation expense 3,498 3,326
Gain on sale of real estate assets, net (94,712) 0
Amortization related to derivative instruments 314 302
Casualty (gains) losses (1,393) 359
Other income (expense), net (380) 0
Changes in assets and liabilities:    
Other assets 4,538 (90)
Accounts payable and accrued expenses (23,326) (1,321)
Accrued interest payable (220) (88)
Other liabilities (958) 141
Cash flow provided by operating activities 40,580 20,638
Cash flows from investing activities:    
Acquisition of real estate properties 0 (365)
Investments in unconsolidated real estate entities (18,605) 0
Disposition of real estate properties, net 155,639 0
Capital expenditures (11,798) (6,916)
Additions to real estate under development (8,040) 0
Proceeds from insurance claims 9,870 0
Cash flow provided by (used in) investing activities 127,066 (7,281)
Cash flows from financing activities:    
Proceeds (costs) from issuance of common stock (844) (59)
Proceeds from unsecured credit facility and term loans 16,500 9,500
Unsecured credit facility repayments (176,000) 0
Mortgage principal repayments (1,864) (7,918)
Payments for deferred financing costs (49) 0
Distributions on common stock (16,916) (12,450)
Distributions to noncontrolling interests (201) (81)
Repurchase of shares related to equity award tax withholding (3,183) (2,862)
Cash flow used in financing activities (182,557) (13,870)
Net change in cash and cash equivalents, and restricted cash (14,911) (513)
Cash and cash equivalents, and restricted cash, beginning of period 65,671 13,615
Cash and cash equivalents, and restricted cash, end of the period 50,760 13,102
Reconciliation of cash, cash equivalents, and restricted cash to the Consolidated Balance Sheet    
Cash and cash equivalents 23,971 8,653
Restricted cash 26,789 4,449
Total cash, cash equivalents, and restricted cash, end of period $ 50,760 $ 13,102